Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Herbert, Andrew S."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-48 z 48
    Tytuł:
    Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge
    Autorzy:
    Roberts Paul C
    Sundick Roy
    Heffron Lynn
    Herbert Andrew S
    Pokaż więcej
    Temat:
    Infectious and parasitic diseases
    RC109-216
    Źródło:
    Virology Journal, Vol 6, Iss 1, p 42 (2009)
    Opis pliku:
    electronic resource
    Relacje:
    http://www.virologyj.com/content/6/1/42; https://doaj.org/toc/1743-422X
    Dostęp URL:
    https://doaj.org/article/0daeb58cc1e845c2aeb29d57d3f8e6cd  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.
    Autorzy:
    Carette JE; Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA.
    Raaben M
    Wong AC
    Herbert AS
    Obernosterer G
    Mulherkar N
    Kuehne AI
    Kranzusch PJ
    Griffin AM
    Ruthel G
    Dal Cin P
    Dye JM
    Whelan SP
    Chandran K
    Brummelkamp TR
    Pokaż więcej
    Źródło:
    Nature [Nature] 2011 Aug 24; Vol. 477 (7364), pp. 340-3. Date of Electronic Publication: 2011 Aug 24.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Virus Internalization*
    Carrier Proteins/*metabolism
    Cholesterol/*metabolism
    Ebolavirus/*physiology
    Membrane Glycoproteins/*metabolism
    Animals ; Biological Transport ; Carrier Proteins/genetics ; Cell Line ; Endosomes/metabolism ; Fibroblasts/metabolism ; Fibroblasts/pathology ; Fibroblasts/virology ; Genome, Human/genetics ; Glycoproteins/metabolism ; Haploidy ; Hemorrhagic Fever, Ebola/drug therapy ; Hemorrhagic Fever, Ebola/metabolism ; Host-Pathogen Interactions/genetics ; Humans ; Intracellular Signaling Peptides and Proteins ; Lysosomes/metabolism ; Marburg Virus Disease/drug therapy ; Marburg Virus Disease/metabolism ; Marburgvirus/physiology ; Membrane Fusion/genetics ; Membrane Fusion/physiology ; Membrane Glycoproteins/deficiency ; Membrane Glycoproteins/genetics ; Multiprotein Complexes/chemistry ; Multiprotein Complexes/deficiency ; Multiprotein Complexes/genetics ; Multiprotein Complexes/metabolism ; Mutation/genetics ; Niemann-Pick C1 Protein ; Niemann-Pick Diseases/pathology ; Niemann-Pick Diseases/virology ; Receptors, Virus/metabolism ; Vesicular Transport Proteins ; Viral Fusion Proteins/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor.
    Autorzy:
    Krishnan A; Department of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA. />Miller EH
    Herbert AS
    Ng M
    Ndungo E
    Whelan SP
    Dye JM
    Chandran K
    Pokaż więcej
    Źródło:
    Viruses [Viruses] 2012 Oct 25; Vol. 4 (11), pp. 2471-84. Date of Electronic Publication: 2012 Oct 25.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Virus Internalization*
    Filoviridae/*physiology
    Membrane Glycoproteins/*chemistry
    Membrane Glycoproteins/*metabolism
    Membrane Transport Proteins/*chemistry
    Membrane Transport Proteins/*metabolism
    Receptors, Virus/*metabolism
    Amino Acid Sequence ; Animals ; Cell Line ; Cricetinae ; Humans ; Molecular Sequence Data ; Protein Binding ; Protein Interaction Domains and Motifs/physiology ; Sequence Alignment ; Viral Envelope Proteins/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Virus entry. Lassa virus entry requires a trigger-induced receptor switch.
    Autorzy:
    Jae LT; Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
    Raaben M; Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands. Department of Microbiology and Immunobiology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
    Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702-5011, USA.
    Kuehne AI; U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702-5011, USA.
    Wirchnianski AS; U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702-5011, USA.
    Soh TK; Department of Microbiology and Immunobiology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
    Stubbs SH; Department of Microbiology and Immunobiology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
    Janssen H; Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
    Damme M; Biochemisches Institut, Christian Albrechts-Universität Kiel, 24118 Kiel, Germany.
    Saftig P; Biochemisches Institut, Christian Albrechts-Universität Kiel, 24118 Kiel, Germany.
    Whelan SP; Department of Microbiology and Immunobiology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA. _.
    Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702-5011, USA. _.
    Brummelkamp TR; Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands. CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria. Cancer Genomics Center (CGC.nl), Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands. _.
    Pokaż więcej
    Źródło:
    Science (New York, N.Y.) [Science] 2014 Jun 27; Vol. 344 (6191), pp. 1506-10.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Virus Internalization*
    Lassa virus/*physiology
    Lysosomal-Associated Membrane Protein 1/*metabolism
    Receptors, Virus/*metabolism
    Viral Envelope Proteins/*metabolism
    Amino Acid Sequence ; Animals ; Cell Line ; Cell Membrane/metabolism ; Cell Membrane/virology ; Cells, Cultured ; Chickens ; Dystroglycans/genetics ; Dystroglycans/metabolism ; Glycosylation ; Humans ; Hydrogen-Ion Concentration ; Lassa Fever/virology ; Lysosomal-Associated Membrane Protein 1/chemistry ; Lysosomes/metabolism ; Lysosomes/virology ; Mice ; Mice, Knockout ; Molecular Sequence Data ; Protein Binding ; Sialyltransferases/metabolism ; beta-Galactoside alpha-2,3-Sialyltransferase
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Immune Memory to Sudan Virus: Comparison between Two Separate Disease Outbreaks.
    Autorzy:
    Sobarzo, Ariel
    Eskira, Yael
    Herbert, Andrew S. anderw.s.herbert.
    Kuehne, Ana I.
    Stonier, Spencer W. spencer.w.stonier2.
    Ochayon, David E.
    Fedida-Metula, Shlomit
    Balinandi, Steven
    Kislev, Yaara
    Tali, Neta
    Lewis, Eli C.
    Lutwama, Julius Julian
    Dye, John M.
    Yavelsky, Victoria
    Lobel, Leslie
    Pokaż więcej
    Źródło:
    Viruses (1999-4915). 2015, Vol. 7 Issue 1, p37-51. 15p.
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets.
    Autorzy:
    Clinton, Tracy R.
    Weinstock, Matthew T.
    Jacobsen, Michael T.
    Szabo‐Fresnais, Nicolas
    Pandya, Maya J.
    Whitby, Frank G.
    Herbert, Andrew S.
    Prugar, Laura I.
    McKinnon, Rena
    Hill, Christopher P.
    Welch, Brett D.
    Dye, John M.
    Eckert, Debra M.
    Kay, Michael S.
    Pokaż więcej
    Źródło:
    Protein Science: A Publication of the Protein Society; Apr2015, Vol. 24 Issue 4, p446-463, 18p
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats.
    Autorzy:
    Melinda Ng
    Ndungo, Esther
    Kaczmarek, Maria E.
    Herbert, Andrew S.
    Binger, Tabea
    Kuehne, Ana I.
    Jangra, Rohit K.
    Hawkins, John A.
    Gifford, Robert J.
    Biswas, Rohan
    Demogines, Ann
    James, Rebekah M.
    Meng Yu
    Brummelkamp, Thijn R.
    Drosten, Christian
    Lin-Fa Wang
    Kuhn, Jens H.
    Müller, Marcel A.
    Dye, John M.
    Sawyer, Sara L.
    Pokaż więcej
    Źródło:
    eLife. Dec2015, p1-22. 22p. 7 Color Photographs.
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle.
    Autorzy:
    Dye JM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
    Wu H; SAB Biotherapeutics, Sioux Falls, South Dakota, United States of America.
    Hooper JW; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
    Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, Maryland, USA.
    Kuehne AI; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
    Coyle EM; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, Maryland, USA.
    Ortiz RA; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
    Fuentes S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, Maryland, USA.
    Herbert AS; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
    Golding H; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, Maryland, USA.
    Bakken RA; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
    Brannan JM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
    Kwilas SA; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
    Sullivan EJ; SAB Biotherapeutics, Sioux Falls, South Dakota, United States of America.
    Luke TC; Viral and Rickettsial Diseases Department, Navy Medical Research Center, The Henry Jackson Foundation, Silver Spring, Maryland, USA.
    Smith G; Novavax Inc, Gaithersburg, Maryland, USA.
    Glenn G; Novavax Inc, Gaithersburg, Maryland, USA.
    Li W; Department of Microbiology and Immunology and Emory Vaccine Center, Emory University, Atlanta, Georgia, 30322, USA.
    Ye L; Department of Microbiology and Immunology and Emory Vaccine Center, Emory University, Atlanta, Georgia, 30322, USA.
    Yang C; Department of Microbiology and Immunology and Emory Vaccine Center, Emory University, Atlanta, Georgia, 30322, USA.
    Compans RW; Department of Microbiology and Immunology and Emory Vaccine Center, Emory University, Atlanta, Georgia, 30322, USA.
    Tripp RA; The University of Georgia, Athens, Georgia, 30602, USA.
    Jiao JA; SAB Biotherapeutics, Sioux Falls, South Dakota, United States of America.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2016 Apr 25; Vol. 6, pp. 24897. Date of Electronic Publication: 2016 Apr 25.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Animals, Genetically Modified*
    Cattle*
    Antibodies, Viral/*blood
    Antibodies, Viral/*therapeutic use
    Ebolavirus/*immunology
    Hemorrhagic Fever, Ebola/*prevention & control
    Animals ; Disease Models, Animal ; Enzyme-Linked Immunosorbent Assay ; Humans ; Immunization, Passive ; Immunoglobulin G/blood ; Immunoglobulin G/therapeutic use ; Mice, Inbred BALB C ; Neutralization Tests ; Surface Plasmon Resonance ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    A "Trojan horse" bispecific-antibody strategy for broad protection against ebolaviruses.
    Autorzy:
    Wec AZ; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
    Nyakatura EK; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
    Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA.
    Howell KA; Integrated Biotherapeutics Inc., Gaithersburg, MD 20878, USA.
    Holtsberg FW; Integrated Biotherapeutics Inc., Gaithersburg, MD 20878, USA.
    Bakken RR; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA.
    Mittler E; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
    Christin JR; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
    Shulenin S; Integrated Biotherapeutics Inc., Gaithersburg, MD 20878, USA.
    Jangra RK; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
    Bharrhan S; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
    Kuehne AI; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA.
    Bornholdt ZA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 10550, USA.
    Flyak AI; Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN 37235, USA.
    Saphire EO; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 10550, USA.; The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 10550, USA.
    Crowe JE Jr; Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN 37235, USA. .; Department of Pediatrics, Vanderbilt University, Nashville, TN 37232, USA.; Vanderbilt Vaccine Center, Vanderbilt University, Nashville, TN 37232, USA.
    Aman MJ; Integrated Biotherapeutics Inc., Gaithersburg, MD 20878, USA. .
    Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA. .
    Lai JR; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA. .
    Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. .
    Pokaż więcej
    Źródło:
    Science (New York, N.Y.) [Science] 2016 Oct 21; Vol. 354 (6310), pp. 350-354. Date of Electronic Publication: 2016 Sep 08.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antibodies, Bispecific/*immunology
    Antibodies, Neutralizing/*immunology
    Antibodies, Viral/*immunology
    Carrier Proteins/*immunology
    Ebolavirus/*immunology
    Hemorrhagic Fever, Ebola/*prevention & control
    Membrane Glycoproteins/*immunology
    Receptors, Virus/*immunology
    Viral Envelope Proteins/*immunology
    Animals ; Antibodies, Monoclonal/immunology ; Binding Sites/immunology ; Cell Line, Tumor ; Endosomes/virology ; Hemorrhagic Fever, Ebola/therapy ; Humans ; Immunotherapy/methods ; Intracellular Signaling Peptides and Proteins ; Mice ; Mice, Inbred BALB C ; Niemann-Pick C1 Protein ; Virus Internalization
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail.
    Autorzy:
    Froude JW; US Army Medical Research Institute for Infectious Disease (USAMRIID), Fort Detrick, MD 21702, USA. .
    Herbert AS; US Army Medical Research Institute for Infectious Disease (USAMRIID), Fort Detrick, MD 21702, USA. andrew.s..
    Pelat T; Unite de Biotechnologie des Anticorps, Institut de Recherche Biomedicale des Armees (IRBA-CRSSA), La Tronche 38516, France. .
    Miethe S; Institut für Biochemie, Biotechnologie und Bioinformatik, Technische Universität Braunschweig, Braunschweig 38106, Germany. .
    Zak SE; US Army Medical Research Institute for Infectious Disease (USAMRIID), Fort Detrick, MD 21702, USA. .
    Brannan JM; US Army Medical Research Institute for Infectious Disease (USAMRIID), Fort Detrick, MD 21702, USA. .
    Bakken RR; US Army Medical Research Institute for Infectious Disease (USAMRIID), Fort Detrick, MD 21702, USA. .
    Steiner AR; Sutro Biopharma Inc., South San Francisco, CA 94080, USA. .
    Yin G; Sutro Biopharma Inc., South San Francisco, CA 94080, USA. .
    Hallam TJ; Sutro Biopharma Inc., South San Francisco, CA 94080, USA. .
    Sato AK; Sutro Biopharma Inc., South San Francisco, CA 94080, USA. .
    Hust M; Institut für Biochemie, Biotechnologie und Bioinformatik, Technische Universität Braunschweig, Braunschweig 38106, Germany. .
    Thullier P; Unite de Biotechnologie des Anticorps, Institut de Recherche Biomedicale des Armees (IRBA-CRSSA), La Tronche 38516, France. .
    Dye JM; US Army Medical Research Institute for Infectious Disease (USAMRIID), Fort Detrick, MD 21702, USA. .
    Pokaż więcej
    Źródło:
    Viruses [Viruses] 2018 May 26; Vol. 10 (6). Date of Electronic Publication: 2018 May 26.
    Typ publikacji:
    Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Ebolavirus*
    Post-Exposure Prophylaxis*
    Antibodies, Viral/*pharmacology
    Hemorrhagic Fever, Ebola/*therapy
    Membrane Glycoproteins/*immunology
    Vaccines, Virus-Like Particle/*immunology
    Viral Matrix Proteins/*immunology
    Animals ; Antibodies, Neutralizing/pharmacology ; Cell Surface Display Techniques ; Cross Reactions ; Female ; Macaca ; Male ; Mice ; Mice, Knockout ; Single-Chain Antibodies/pharmacology ; Vaccination
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Broad neutralization of SARS-related viruses by human monoclonal antibodies.
    Autorzy:
    Wec AZ; Adimab LLC, Lebanon, NH 03766, USA.
    Wrapp D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
    Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
    Maurer DP; Adimab LLC, Lebanon, NH 03766, USA.
    Haslwanter D; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10462, USA.
    Sakharkar M; Adimab LLC, Lebanon, NH 03766, USA.
    Jangra RK; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10462, USA.
    Dieterle ME; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10462, USA.
    Lilov A; Adimab LLC, Lebanon, NH 03766, USA.
    Huang D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
    Tse LV; Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
    Johnson NV; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
    Hsieh CL; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
    Wang N; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
    Nett JH; Adimab LLC, Lebanon, NH 03766, USA.
    Champney E; Adimab LLC, Lebanon, NH 03766, USA.
    Burnina I; Adimab LLC, Lebanon, NH 03766, USA.
    Brown M; Adimab LLC, Lebanon, NH 03766, USA.
    Lin S; Adimab LLC, Lebanon, NH 03766, USA.
    Sinclair M; Adimab LLC, Lebanon, NH 03766, USA.
    Johnson C; Adimab LLC, Lebanon, NH 03766, USA.
    Pudi S; Adimab LLC, Lebanon, NH 03766, USA.
    Bortz R 3rd; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10462, USA.
    Wirchnianski AS; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10462, USA.
    Laudermilch E; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10462, USA.
    Florez C; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10462, USA.
    Fels JM; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10462, USA.
    O'Brien CM; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
    Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
    Nemazee D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
    Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA 02139, USA.
    Baric RS; Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Departments of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
    Voss JE; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
    Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10462, USA.
    Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
    McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
    Walker LM; Adimab LLC, Lebanon, NH 03766, USA. .
    Pokaż więcej
    Źródło:
    Science (New York, N.Y.) [Science] 2020 Aug 07; Vol. 369 (6504), pp. 731-736. Date of Electronic Publication: 2020 Jun 15.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antibodies, Monoclonal/*immunology
    Antibodies, Viral/*immunology
    Betacoronavirus/*immunology
    Broadly Neutralizing Antibodies/*immunology
    Severe acute respiratory syndrome-related coronavirus/*immunology
    Spike Glycoprotein, Coronavirus/*immunology
    Adult ; Aged ; Angiotensin-Converting Enzyme 2 ; Antibody Affinity ; B-Lymphocyte Subsets/immunology ; Binding Sites ; Cross Reactions ; Epitopes ; Female ; Humans ; Immunologic Memory ; Male ; Middle Aged ; Neutralization Tests ; Peptidyl-Dipeptidase A/chemistry ; Peptidyl-Dipeptidase A/metabolism ; Protein Domains ; Receptors, Coronavirus ; Receptors, Virus/chemistry ; Receptors, Virus/metabolism ; SARS-CoV-2 ; Severe Acute Respiratory Syndrome/immunology ; Somatic Hypermutation, Immunoglobulin ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/metabolism ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.
    Autorzy:
    Chan KK; Orthogonal Biologics, Champaign, IL 61821, USA.
    Dorosky D; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
    Sharma P; Department of Biochemistry and Cancer Center at Illinois, University of Illinois, Urbana, IL 61801, USA.
    Abbasi SA; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
    Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
    Kranz DM; Department of Biochemistry and Cancer Center at Illinois, University of Illinois, Urbana, IL 61801, USA.
    Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.; The Geneva Foundation, Tacoma, WA 98402, USA.
    Procko E; Department of Biochemistry and Cancer Center at Illinois, University of Illinois, Urbana, IL 61801, USA. .
    Pokaż więcej
    Źródło:
    Science (New York, N.Y.) [Science] 2020 Sep 04; Vol. 369 (6508), pp. 1261-1265. Date of Electronic Publication: 2020 Aug 04.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Protein Engineering*
    Betacoronavirus/*metabolism
    Peptidyl-Dipeptidase A/*genetics
    Peptidyl-Dipeptidase A/*metabolism
    Receptors, Virus/*genetics
    Receptors, Virus/*metabolism
    Spike Glycoprotein, Coronavirus/*metabolism
    Amino Acid Substitution ; Angiotensin-Converting Enzyme 2 ; Binding Sites ; Binding, Competitive ; Cell Line ; Humans ; Models, Molecular ; Mutagenesis ; Mutation ; Peptidyl-Dipeptidase A/chemistry ; Protein Binding ; Protein Interaction Domains and Motifs ; Protein Multimerization ; Receptors, Coronavirus ; Receptors, Virus/chemistry ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/chemistry
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
    Autorzy:
    Rappazzo CG; Adimab, LLC, Lebanon, NH 03766, USA.
    Tse LV; Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
    Kaku CI; Adimab, LLC, Lebanon, NH 03766, USA.
    Wrapp D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
    Sakharkar M; Adimab, LLC, Lebanon, NH 03766, USA.
    Huang D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
    Deveau LM; Adimab, LLC, Lebanon, NH 03766, USA.
    Yockachonis TJ; Paul G. Allen School of Global Animal Health, Washington State University, Pullman, WA 99164, USA.
    Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.; The Geneva Foundation, Tacoma, WA 98402, USA.
    Battles MB; Adimab, LLC, Lebanon, NH 03766, USA.
    O'Brien CM; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.; The Geneva Foundation, Tacoma, WA 98402, USA.
    Brown ME; Adimab, LLC, Lebanon, NH 03766, USA.
    Geoghegan JC; Adimab, LLC, Lebanon, NH 03766, USA.
    Belk J; Adimab, LLC, Lebanon, NH 03766, USA.
    Peng L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
    Yang L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
    Hou Y; Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
    Scobey TD; Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
    Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA 02139, USA.
    Nemazee D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
    Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
    Voss JE; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
    Gunn BM; Paul G. Allen School of Global Animal Health, Washington State University, Pullman, WA 99164, USA.
    McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
    Baric RS; Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. .; Departments of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
    Gralinski LE; Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. .
    Walker LM; Adimab, LLC, Lebanon, NH 03766, USA. .; Adagio Therapeutics, Inc., Waltham, MA 02451, USA.
    Pokaż więcej
    Źródło:
    Science (New York, N.Y.) [Science] 2021 Feb 19; Vol. 371 (6531), pp. 823-829. Date of Electronic Publication: 2021 Jan 25.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Antibodies, Monoclonal/*immunology
    Antibodies, Viral/*immunology
    Betacoronavirus/*immunology
    Broadly Neutralizing Antibodies/*immunology
    SARS-CoV-2/*immunology
    Spike Glycoprotein, Coronavirus/*immunology
    Angiotensin-Converting Enzyme 2/metabolism ; Animals ; Antibodies, Monoclonal/genetics ; Antibodies, Monoclonal/metabolism ; Antibodies, Viral/genetics ; Antibodies, Viral/metabolism ; Antibody Affinity ; Binding Sites ; Binding Sites, Antibody ; Broadly Neutralizing Antibodies/genetics ; Broadly Neutralizing Antibodies/metabolism ; COVID-19/prevention & control ; COVID-19/therapy ; Cell Surface Display Techniques ; Directed Molecular Evolution ; Epitopes/immunology ; Humans ; Immunization, Passive ; Immunoglobulin Fc Fragments/immunology ; Mice, Inbred BALB C ; Protein Domains ; Protein Engineering ; Receptors, Coronavirus/metabolism ; Severe acute respiratory syndrome-related coronavirus/immunology ; Severe Acute Respiratory Syndrome/immunology ; Severe Acute Respiratory Syndrome/prevention & control ; Severe Acute Respiratory Syndrome/therapy ; Spike Glycoprotein, Coronavirus/metabolism ; COVID-19 Serotherapy ; Mice
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.
    Autorzy:
    Voss WN; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    Hou YJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
    Johnson NV; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    Delidakis G; Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
    Kim JE; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.
    Javanmardi K; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    Horton AP; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    Bartzoka F; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    Paresi CJ; Department of Chemistry, The University of Texas at Austin, Austin, TX, USA.
    Tanno Y; Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
    Chou CW; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    Abbasi SA; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
    Pickens W; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    George K; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    Boutz DR; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.; CCDC Army Research Laboratory-South, The University of Texas at Austin, Austin, TX, USA.
    Towers DM; Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
    McDaniel JR; Biomedicine Design, Pfizer, Cambridge, MA, USA.
    Billick D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    Goike J; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    Rowe L; Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Tulane National Primate Research Center Department of Microbiology 18703 Three Rivers Road Covington, LA, USA.
    Batra D; Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
    Pohl J; Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
    Lee J; Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
    Gangappa S; Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
    Sambhara S; Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
    Gadush M; Center for Biomedical Research Support, The University of Texas at Austin, Austin, TX, USA.
    Wang N; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    Person MD; Center for Biomedical Research Support, The University of Texas at Austin, Austin, TX, USA.
    Iverson BL; Department of Chemistry, The University of Texas at Austin, Austin, TX, USA.
    Gollihar JD; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.; CCDC Army Research Laboratory-South, The University of Texas at Austin, Austin, TX, USA.; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA.
    Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
    Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
    Finkelstein IJ; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
    McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
    Georgiou G; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.; Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.; Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
    Lavinder JJ; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA. .; Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
    Ippolito GC; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA. .; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA.; Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
    Pokaż więcej
    Źródło:
    Science (New York, N.Y.) [Science] 2021 Jun 04; Vol. 372 (6546), pp. 1108-1112. Date of Electronic Publication: 2021 May 04.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Antibodies, Neutralizing/*immunology
    Antibodies, Viral/*immunology
    COVID-19/*immunology
    Immunoglobulin G/*immunology
    SARS-CoV-2/*immunology
    Spike Glycoprotein, Coronavirus/*immunology
    Animals ; Antibodies, Monoclonal/blood ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/immunology ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/chemistry ; Antibodies, Viral/blood ; Antibodies, Viral/chemistry ; Antibody Affinity ; COVID-19/prevention & control ; Epitopes/immunology ; Humans ; Immune Evasion ; Immunoglobulin G/blood ; Immunoglobulin G/chemistry ; Immunoglobulin Heavy Chains/immunology ; Immunoglobulin Variable Region/immunology ; Mice ; Mice, Inbred BALB C ; Mutation ; Protein Domains ; Proteomics ; SARS-CoV-2/genetics ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach.
    Autorzy:
    Gupta, Yash (AUTHOR)
    Kumar, Sumit (AUTHOR)
    Zak, Samantha E. (AUTHOR)
    Jones, Krysten A. (AUTHOR)
    Upadhyay, Charu (AUTHOR)
    Sharma, Neha (AUTHOR)
    Azizi, Saara-Anne (AUTHOR)
    Kathayat, Rahul S. (AUTHOR)
    Poonam (AUTHOR)
    Herbert, Andrew S. (AUTHOR)
    Durvasula, Ravi (AUTHOR)
    Dickinson, Bryan C. (AUTHOR)
    Dye, John M. (AUTHOR)
    Rathi, Brijesh (AUTHOR)
    Kempaiah, Prakasha (AUTHOR)
    Pokaż więcej
    Źródło:
    Bioorganic & Medicinal Chemistry. Oct2021, Vol. 47, pN.PAG-N.PAG. 1p.
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity.
    Autorzy:
    Wirchnianski, Ariel S.
    Wec, Anna Z.
    Nyakatura, Elisabeth K.
    Herbert, Andrew S.
    Slough, Megan M.
    Kuehne, Ana I.
    Mittler, Eva
    Jangra, Rohit K.
    Teruya, Jonathan
    Dye, John M.
    Lai, Jonathan R.
    Chandran, Kartik
    Pokaż więcej
    Temat:
    BISPECIFIC antibodies
    IMMUNOGLOBULINS
    MONOCLONAL antibodies
    THERAPEUTICS
    EBOLA virus
    Źródło:
    Frontiers in Immunology; 10/14/2021, Vol. 12, p1-13, 13p
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays.
    Autorzy:
    Gupta, Yash (AUTHOR)
    Maciorowski, Dawid (AUTHOR)
    Zak, Samantha E. (AUTHOR)
    Jones, Krysten A. (AUTHOR)
    Kathayat, Rahul S. (AUTHOR)
    Azizi, Saara-Anne (AUTHOR)
    Mathur, Raman (AUTHOR)
    Pearce, Catherine M (AUTHOR)
    Ilc, David J. (AUTHOR)
    Husein, Hamza (AUTHOR)
    Herbert, Andrew S. (AUTHOR)
    Bharti, Ajay (AUTHOR)
    Rathi, Brijesh (AUTHOR)
    Durvasula, Ravi (AUTHOR)
    Becker, Daniel P. (AUTHOR)
    Dickinson, Bryan C. (AUTHOR)
    Dye, John M. (AUTHOR)
    Kempaiah, Prakasha (AUTHOR)
    Pokaż więcej
    Źródło:
    Methods. Nov2021, Vol. 195, p57-71. 15p.
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    SARS-CoV-2 Aerosol and Intranasal Exposure Models in Ferrets.
    Autorzy:
    Zumbrun EE; Division of Virology, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Zak SE; Division of Virology, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Lee ED; Division of Pathology, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Bowling PA; Division of Veterinary Medicine, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Ruiz SI; Division of Bacteriology, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Zeng X; Division of Pathology, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Koehler JW; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Delp KL; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Bakken RR; Division of Virology, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Hentschel SS; Division of Virology, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Bloomfield HA; Division of Pathology, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Ricks KM; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Clements TL; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Babka AM; Division of Pathology, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Dye JM; Division of Virology, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Herbert AS; Division of Virology, United States Army Medical Research Institute of Infectious Disease, Frederick, MD 21702, USA.
    Pokaż więcej
    Źródło:
    Viruses [Viruses] 2023 Nov 29; Vol. 15 (12). Date of Electronic Publication: 2023 Nov 29.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    SARS-CoV-2*
    COVID-19*
    Animals ; Humans ; Ferrets ; COVID-19 Vaccines ; Pandemics ; Respiratory Aerosols and Droplets ; Disease Models, Animal
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Author Correction: Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection
    Autorzy:
    Slough, Megan M.
    Li, Rong
    Herbert, Andrew S.
    Lasso, Gorka
    Kuehne, Ana I.
    Monticelli, Stephanie R.Aff3, Aff4
    Bakken, Russell R.
    Liu, Yanan
    Ghosh, Agnidipta
    Moreau, Alicia M.
    Zeng, Xiankun
    Rey, Félix A.
    Guardado-Calvo, PabloAff6, Aff7
    Almo, Steven C.
    Dye, John M.
    Jangra, Rohit K.Aff1, Aff8, IDs4146702341659y_cor16
    Wang, ZhongdeAff2, IDs4146702341659y_cor17
    Chandran, KartikAff1, IDs4146702341659y_cor18
    Pokaż więcej
    Źródło:
    Nature Communications. 14(1)
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies.
    Autorzy:
    Wirchnianski AS; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America.
    Nyakatura EK; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.
    Herbert AS; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America.
    Kuehne AI; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.
    Abbasi SA; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America.
    Florez C; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America.
    Storm N; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America.
    McKay LGA; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America.
    Dailey L; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.
    Kuang E; The Geneva Foundation, Tacoma, Washington, United States of America.
    Abelson DM; The Geneva Foundation, Tacoma, Washington, United States of America.
    Wec AZ; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America.
    Chakraborti S; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.
    Holtsberg FW; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America.
    Shulenin S; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America.
    Bornholdt ZA; Mapp Biopharmaceutical Inc., San Diego, California, United States of America.
    Aman MJ; Mapp Biopharmaceutical Inc., San Diego, California, United States of America.
    Honko AN; The Geneva Foundation, Tacoma, Washington, United States of America.
    Griffiths A; The Geneva Foundation, Tacoma, Washington, United States of America.
    Dye JM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.
    Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America.
    Lai JR; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2024 Apr 11; Vol. 20 (4), pp. e1012134. Date of Electronic Publication: 2024 Apr 11.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-48 z 48

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies